$80,000,000 Settlement Involving Pharmaceutical
General Pharmaceutical | Landmark Verdict
Buyers Beware: Generic drug makers not required to warn of new drug...
General Pharmaceutical | July 1, 2011
Beasley Allen files second lawsuit related to contaminated IV death
General Pharmaceutical | April 14, 2011
Beasley Allen files wrongful death lawsuit linked to tainted IV fluid
General Pharmaceutical | March 31, 2011
General Pharmaceutical | Landmark Verdict
Published: January 16, 2008
Over 700,000 Americans had used the drug Baycol before it was withdrawn from the market in August 2001. Many deaths were linked to Baycol as were cases of renal failure requiring dialysis. Muscle pain, weakness, tenderness, fever, dark urine, nausea, and vomiting are symptoms of rhabdomyolysis. The litigation focused on Bayer's early knowledge of Baycol being much more potent than other statins and it's much higher risk to patients. Over 3000 rhabdomyolysis claims have been settled since the withdrawal with over $1 billion paid to those injured. Beasley Allen personally handled over 80 million dollars of these claims.
Related News
Buyers Beware: Generic drug makers not required to warn of new drug...
General Pharmaceutical | July 1, 2011
Beasley Allen files second lawsuit related to contaminated IV death
General Pharmaceutical | April 14, 2011
Beasley Allen files wrongful death lawsuit linked to tainted IV fluid
General Pharmaceutical | March 31, 2011


